Reinvent the way pharma industries are interacting with healthcare professional (and patients)
Medical devices and pharmaceutical companies are dramatically changing their operating model to reinvent the way they are interacting with the healthcare system, especially healthcare professionals (HCP) in a post-covid area. Virtual interactions have been adopted to partly replace traditional face-to-face at an incredible velocity over the past 2 years. Also, we are witnessing a transformation toward tailor-made communication including innovative technologies to cluster a target into subgroups. The overarching goal is to provide the right information to the right stakeholder at the right time while ensuring compliance with restrictive legal framework. Life science industry has already been experiencing virtual and augmented reality for a few years with a broad range of applications.
